| David J Theige, MD | |
|
801 Broadway N, Fargo, ND 58102-3641 | |
| (701) 234-2731 | |
| (701) 234-2158 |
| Full Name | David J Theige |
|---|---|
| Gender | Male |
| Speciality | Hospitalist |
| Experience | 39 Years |
| Location | 801 Broadway N, Fargo, North Dakota |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1245252816 | NPI | - | NPPES |
| 10011 | Medicaid | ND | |
| 823131100 | Medicaid | MN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 5438 (North Dakota) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Sanford Medical Center Fargo | Fargo, ND | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Sanford Medical Center Fargo | 8426967803 | 1094 |
News Archive
Cancer diagnostics company Biomoda, Inc. received Notice of Allowance for a U.S. Patent issued today that expands on use of the CyPath assay to include patient response to cancer therapy during the treatment phase of the disease.
A new study says California hospitals in areas with large minority populations are disproportionately affected by overcrowding at ERs - often leading to ambulance diversion, delayed care and poorer health outcomes for patients.
Covaris Incorporated today announced the introduction of the Bench-top SF220 High Performance Formulation Processing System.
From the transfection experts, Mirus Bio introduces its next generation transfection reagent, TransIT(R)-2020 Transfection Reagent.
› Verified 3 days ago
| Entity Name | Sanford Clinic North |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942241351 PECOS PAC ID: 4284546151 Enrollment ID: O20031112000221 |
News Archive
Cancer diagnostics company Biomoda, Inc. received Notice of Allowance for a U.S. Patent issued today that expands on use of the CyPath assay to include patient response to cancer therapy during the treatment phase of the disease.
A new study says California hospitals in areas with large minority populations are disproportionately affected by overcrowding at ERs - often leading to ambulance diversion, delayed care and poorer health outcomes for patients.
Covaris Incorporated today announced the introduction of the Bench-top SF220 High Performance Formulation Processing System.
From the transfection experts, Mirus Bio introduces its next generation transfection reagent, TransIT(R)-2020 Transfection Reagent.
› Verified 3 days ago
| Entity Name | Sanford Medical Center Fargo |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184917924 PECOS PAC ID: 8426967803 Enrollment ID: O20110331000495 |
News Archive
Cancer diagnostics company Biomoda, Inc. received Notice of Allowance for a U.S. Patent issued today that expands on use of the CyPath assay to include patient response to cancer therapy during the treatment phase of the disease.
A new study says California hospitals in areas with large minority populations are disproportionately affected by overcrowding at ERs - often leading to ambulance diversion, delayed care and poorer health outcomes for patients.
Covaris Incorporated today announced the introduction of the Bench-top SF220 High Performance Formulation Processing System.
From the transfection experts, Mirus Bio introduces its next generation transfection reagent, TransIT(R)-2020 Transfection Reagent.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| David J Theige, MD 801 Broadway N, Fargo, ND 58102-3641 Ph: (701) 234-2731 | David J Theige, MD 801 Broadway N, Fargo, ND 58102-3641 Ph: (701) 234-2731 |
News Archive
Cancer diagnostics company Biomoda, Inc. received Notice of Allowance for a U.S. Patent issued today that expands on use of the CyPath assay to include patient response to cancer therapy during the treatment phase of the disease.
A new study says California hospitals in areas with large minority populations are disproportionately affected by overcrowding at ERs - often leading to ambulance diversion, delayed care and poorer health outcomes for patients.
Covaris Incorporated today announced the introduction of the Bench-top SF220 High Performance Formulation Processing System.
From the transfection experts, Mirus Bio introduces its next generation transfection reagent, TransIT(R)-2020 Transfection Reagent.
› Verified 3 days ago
Abdallah M Mansour, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 3000 32nd Ave S, Fargo, ND 58103 Phone: 701-364-8900 | |
Derek Anderson, DO Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 5225 23rd Ave S, Fargo, ND 58104 Phone: 701-234-5933 | |
Gerald G Gross, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 820 4th St N, Fargo, ND 58102 Phone: 701-234-6161 | |
Paul James Carson, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 801 Broadway N, Fargo, ND 58102 Phone: 701-234-4811 Fax: 701-234-6979 | |
Howard L Russell, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 820 N 4th St, Fargo, ND 58122 Phone: 701-234-6161 Fax: 701-234-3861 | |
Dr. Emuejevoke Joseph Okoh, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 801 Broadway N, Fargo, ND 58102 Phone: 701-234-2000 | |
Dr. Patrick J Hughes, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 801 Broadway N, Fargo, ND 58102 Phone: 201-234-2000 |